Authors:
Roberts, JD
Shibata, S
Spicer, DV
McLeod, HL
Tombes, MB
Kyle, B
Carroll, M
Sheedy, B
Collier, MA
Pithavala, YK
Paradiso, LJ
Clendeninn, NJ
Citation: Jd. Roberts et al., Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks, CANC CHEMOT, 45(5), 2000, pp. 423-427